Concerns Regarding Injections: When injecting BPC-157 or TB-500, there is a risk of injection site reactions such as pain, redness, or swelling
The peptide does not suddenly become useless on day 29
no LD50 established even at very high doses in rodents No Hormonal Effects: Does not affect testosterone, estrogen, growth hormone, or other hormonal axes Gastric Origin: Derived from a naturally occurring human gastric protein, suggesting good biological compatibility Stability: Unusually stable in gastric acid, supporting oral administration potential Reported Effects: Anecdotal reports of fatigue, nausea in some research subjects TB-500 Safety Profile: (PMID: 20536472) Note: Published safety data is primarily available for Thymosin Beta-4
Due to the lack of regulatory approval and comprehensive human pharmacokinetic data, users often adjust doses based on personal response and tolerance
Sermorelin, GHK-Cu, NAD+, and glutathione are commonly administered this way